- idUS
- Listar por autor
Listar por autor "Ascierto, Paolo Antonio"
Mostrando ítems 1-2 de 2
-
Artículo
5-year outcomes with cobimetinib plus vemurafenib in BRAFV600 mutation⇓positive advanced melanoma: extended follow-up of the coBRIM study
Ascierto, Paolo Antonio; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Cruz Merino, Luis de la; McArthur, Grant A. (American Association for Cancer Research, 2021)Purpose: The randomized phase III coBRIM study (NCT01689519) demonstrated improved progression-free survival (PFS) and ...
-
Artículo
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
Mandala, Mario; Larkin, James R.; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cruz Merino, Luis de la; Weber, Jeffrey; Lobo, Maurice (BMJ Publishing Group, 2021-08-21)Background Several therapeutic options are now available in the adjuvant melanoma setting, mandating an understanding ...